Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

X4 Pharmaceuticals

Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2017 Colt

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$197M
Market cap · Apr/2026
Revenue
$35M
Latest reported FY

Investors

4 investors on X4 Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Series B+ 3 investors entered at this stage

Global footprint

Where X4 Pharmaceuticals has talent and traffic

Web traffic by country
3.4K monthly visits
across markets
🇺🇸 United States94.1%
🇵🇭 Philippines5.9%
Top 2 markets shown

See X4 Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.